Funding · Company
Crossbow Therapeutics, Inc.
Cambridge, MABiotech & Pharma
Crossbow Therapeutics, Inc. of Cambridge, MA has disclosed $68M across 2 Form D offerings filed with the SEC between Apr 12, 2023 and Sep 30, 2025.
$68M
Total disclosed
2
Form D offerings
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$30M
Form D · Sep 30, 2025 ↗
Q3 2025
· target $80M
$38M
Form D · Apr 12, 2023 ↗
Q2 2023
· target $80M
Filing details
HeadquartersCambridge, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001972912Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →